Table 1.
Patient | Sex | Age | FLAIR Volume (cm3) |
Contrast-Enhanced Volume (cm3) |
---|---|---|---|---|
sub-001 | M | 76 | 60 | 23 |
sub-002 | F | 76 | 37 | 9 |
sub-003 | M | 66 | 92 | 8 |
sub-006 | F | 73 | 66 | 14 |
sub-007 | M | 59 | 151 | 36 |
sub-008 | F | 57 | 37 | 22 |
sub-009 | F | 72 | 39 | 19 |
sub-010 | M | 52 | 114 | 23 |
sub-012 | M | 62 | 166 | 15 |
sub-013 | F | 60 | 92 | 32 |
sub-014 | M | 72 | 26 | 1 |
sub-015 | M | 73 | 79 | 17 |
sub-017 | M | 49 | 22 | 2 |
sub-019 | M | 78 | 14 | 3 |
sub-020 | M | 37 | 90 | 10 |
sub-021 | M | 56 | 31 | 11 |
MEDIAN | 64 | 63 | 15 | |
MIN | 376 | 14 | 1 | |
MAX | 787 | 166 | 36 |
Progression was evaluated according to RANO criteria [29].